Immunoregulation in Cardiovascular Disease

A special issue of Cells (ISSN 2073-4409).

Deadline for manuscript submissions: 10 November 2025 | Viewed by 54

Special Issue Editor


E-Mail Website
Guest Editor
Lewis Katz School of Medicine, Temple University, 3500 North Broad Street, Philadelphia, PA 19140, USA
Interests: cardiovascular diseases; hyperlipidemia; hyperglycemia; hyperinsulinemia; hyperhomocysteinemia; obesity; vascular inflammation; diabetes; stroke; peripheral artery disease; myocardial infarction; chronic kidney disease
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

We are pleased to invite you to contribute to our Special Issue on “Immunoregulation in Cardiovascular Disease”. Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide. In recent years, there has been a growing recognition of the crucial role played by the immune system in the development and progression of CVDs.

This Special Issue aims to bring together the latest research on immunoregulation in cardiovascular disease, highlighting the complex interactions between the immune and cardiovascular systems. By understanding these interactions, we hope to identify new therapeutic targets and strategies for preventing and treating CVDs.

In this Special Issue, original research articles and comprehensive reviews are welcome. Research areas may include (but are not limited to) the following:

  • The role of immune cells, such as T, B, macrophages, and dendritic cells, in CVD pathogenesis and systemic inflammation.
  • Immune mediators, including cytokines, chemokines, and adhesion molecules, and their impact on cardiovascular function and systemic inflammation.
  • Mechanisms of immune regulation in atherosclerosis, myocardial infarction, heart failure, and systemic inflammation.
  • The interplay between innate and adaptive immunity in cardiovascular disease and systemic inflammation.
  • Immunomodulatory therapies for CVDs and systemic inflammation including anti-inflammatory drugs, immune checkpoint inhibitors, and cell-based therapies.
  • The role of the microbiome in modulating the immune response and cardiovascular health.
  • Epigenetic regulation of immune responses in CVDs and systemic inflammation.
  • Immune-related biomarkers and therapeutic targeting in CVDs and systemic inflammation.
  • The application of cellular methods/technologies in immune research.

We look forward to receiving your contributions.

Prof. Dr. Hong Wang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cardiovascular disease (CVD)
  • immunoregulation
  • inflammation
  • immune cells
  • immune mediators
  • immunomodulatory therapies
  • biomarkers
  • epigenetics
  • microbiome
  • cellular methods/technologies

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop